Please enable JavaScript to continue using this application.

Compare $ALEC vs $PLX | Chartloom

Compare

$ALEC vs $PLX

Alector Inc · Protalix Biotherapeutics Inc

ALEC

Alector Inc

PLX

Protalix Biotherapeutics Inc

Compare $ALEC vs $PLX

Comparing Alector Inc and Protalix Biotherapeutics Inc

ALECAlector Inc

PLXProtalix Biotherapeutics Inc

ALECAlector Inc

Market cap

$231M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.29x

Rev growth (TTM)

-82.9%

YTD performance

35.9%

52W performance

-32.5%

FCF yield

-68.6%

PLXProtalix Biotherapeutics Inc

Market cap

$224M

P/E (TTM)

12.11x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.56x

Rev growth (TTM)

30.1%

YTD performance

59.8%

52W performance

8.2%

FCF yield

3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALEC

PLX

Detailed metrics comparison

ALEC

Alector Inc

PLX

Protalix Biotherapeutics Inc

Market Cap

ALEC$231M

PLX$224M

Enterprise Value

ALEC$181M

PLX$197M

Price

ALEC$2.08

PLX$2.78

P/E Ratio

ALECN/A

PLX12.11x

P/S Ratio

ALEC16.66x

PLX2.78x

EV/Sales

ALEC13.05x

PLX2.44x

EV/EBITDA

ALEC3.60x

PLX7.37x

P/B Ratio

ALEC19.47x

PLX3.06x

P/FCF Ratio

ALECN/A

PLX29.21x

EV/FCF

ALEC-1.14x

PLX25.63x

PEG Ratio

ALECN/A

PLX0.06x

Forward P/E (NTM)

ALECN/A

PLXN/A

Forward P/S (NTM)

ALEC34.29x

PLX3.56x

Revenue (TTM)

ALEC$14M

PLX$81M

Revenue Growth (YoY)

ALEC-82.9%

PLX30.1%

Forward Rev Growth

ALEC281.0%

PLX-19.1%

Gross Margin (TTM)

ALEC0.0%

PLX69.2%

Operating Margin (TTM)

ALEC0.0%

PLX28.9%

EBITDA Margin (TTM)

ALEC-879.7%

PLX30.8%

Net Margin (TTM)

ALEC-850.1%

PLX23.5%

FCF Margin (TTM)

ALEC-1142.6%

PLX9.5%

Net Income (TTM)

ALEC$-118M

PLX$19M

FCF (TTM)

ALEC$-158M

PLX$8M

EPS (TTM)

ALEC-$1.06

PLX$0.23

ROE (TTM)

ALEC-29517.0%

PLX31.6%

ROA (TTM)

ALEC-4400.0%

PLX20.1%

ROIC (TTM)

ALEC-24053.0%

PLX31.6%

Cash

ALEC$60M

PLX$27M

Debt

ALEC$10M

PLX$0

Net Cash/Debt

ALEC$50M

PLX$27M

Current Ratio (TTM)

ALEC5.26x

PLX2.94x

Quick Ratio (TTM)

ALEC5.05x

PLX1.91x

Debt/Equity (TTM)

ALEC0.94x

PLX0.00x

Debt/Assets (TTM)

ALEC0.0%

PLX0.0%

Interest Coverage (TTM)

ALECN/A

PLXN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

PLX0.00x

Beta

ALEC0.65

PLX-0.05

52W Performance

ALEC-32.5%

PLX8.2%

YTD Performance

ALEC35.9%

PLX59.8%

% from 52W High

ALEC-38.8%

PLX-12.9%

% from 52W Low

ALEC90.8%

PLX73.7%

Asset Turnover (TTM)

ALEC0.05x

PLX0.85x

FCF Yield (TTM)

ALEC-68.6%

PLX3.4%

Earnings Yield (TTM)

ALEC-51.0%

PLX8.5%

Dividend Yield (TTM)

ALECN/A

PLXN/A

Rule of 40

ALEC-1,225.5

PLX39.7

EV/GP/RG

ALECN/A

PLXN/A

Ticker research

View ALEC research View PLX research

Metric	ALEC Alector Inc	PLX Protalix Biotherapeutics Inc
Market & Valuation
Market Cap	$231M	$224M
Enterprise Value	$181M	$197M
Price	$2.08	$2.78
P/E Ratio	N/A	12.11x
P/S Ratio	16.66x	2.78x
EV/Sales	13.05x	2.44x
EV/EBITDA	3.60x	7.37x
P/B Ratio	19.47x	3.06x
P/FCF Ratio	N/A	29.21x
EV/FCF	-1.14x	25.63x
PEG Ratio	N/A	0.06x
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	3.56x
Revenue & Growth
Revenue (TTM)	$14M	$81M
Revenue Growth (YoY)	-82.9%	30.1%
Forward Rev Growth	281.0%	-19.1%
Profitability
Gross Margin (TTM)	0.0%	69.2%
Operating Margin (TTM)	0.0%	28.9%
EBITDA Margin (TTM)	-879.7%	30.8%
Net Margin (TTM)	-850.1%	23.5%
FCF Margin (TTM)	-1142.6%	9.5%
Net Income (TTM)	$-118M	$19M
FCF (TTM)	$-158M	$8M
EPS (TTM)	-$1.06	$0.23
ROE (TTM)	-29517.0%	31.6%
ROA (TTM)	-4400.0%	20.1%
ROIC (TTM)	-24053.0%	31.6%
Financial Health
Cash	$60M	$27M
Debt	$10M	$0
Net Cash/Debt	$50M	$27M
Current Ratio (TTM)	5.26x	2.94x
Quick Ratio (TTM)	5.05x	1.91x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	-0.05
52W Performance	-32.5%	8.2%
YTD Performance	35.9%	59.8%
% from 52W High	-38.8%	-12.9%
% from 52W Low	90.8%	73.7%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.85x
FCF Yield (TTM)	-68.6%	3.4%
Earnings Yield (TTM)	-51.0%	8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	39.7
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View PLX research

Valuation

P/E Ratio

PLX

12.11x

P/S Ratio

PLX

2.78x

ALEC

16.66x

EV/FCF

ALEC

-1.14x

PLX

25.63x

Growth & revenue

Revenue Growth TTM

PLX

30.1%

ALEC

-82.9%

Forward Revenue Growth

ALEC

281.0%

PLX

-19.1%

Profitability & performance

Gross Margin

PLX

69.2%

ALEC

0.0%

ROE

PLX

31.6%

ALEC

-29517.0%

FCF Yield %

PLX

3.4%

ALEC

-68.6%

52-Week Performance

PLX

8.2%

ALEC

-32.5%

Detailed metrics comparison

ALEC

Alector Inc

PLX

Protalix Biotherapeutics Inc

Market Cap

ALEC$231M

PLX$224M

Enterprise Value

ALEC$181M

PLX$197M

Price

ALEC$2.08

PLX$2.78

P/E Ratio

ALECN/A

PLX12.11x

P/S Ratio

ALEC16.66x

PLX2.78x

EV/Sales

ALEC13.05x

PLX2.44x

EV/EBITDA

ALEC3.60x

PLX7.37x

P/B Ratio

ALEC19.47x

PLX3.06x

P/FCF Ratio

ALECN/A

PLX29.21x

EV/FCF

ALEC-1.14x

PLX25.63x

PEG Ratio

ALECN/A

PLX0.06x

Forward P/E (NTM)

ALECN/A

PLXN/A

Forward P/S (NTM)

ALEC34.29x

PLX3.56x

Revenue (TTM)

ALEC$14M

PLX$81M

Revenue Growth (YoY)

ALEC-82.9%

PLX30.1%

Forward Rev Growth

ALEC281.0%

PLX-19.1%

Gross Margin (TTM)

ALEC0.0%

PLX69.2%

Operating Margin (TTM)

ALEC0.0%

PLX28.9%

EBITDA Margin (TTM)

ALEC-879.7%

PLX30.8%

Net Margin (TTM)

ALEC-850.1%

PLX23.5%

FCF Margin (TTM)

ALEC-1142.6%

PLX9.5%

Net Income (TTM)

ALEC$-118M

PLX$19M

FCF (TTM)

ALEC$-158M

PLX$8M

EPS (TTM)

ALEC-$1.06

PLX$0.23

ROE (TTM)

ALEC-29517.0%

PLX31.6%

ROA (TTM)

ALEC-4400.0%

PLX20.1%

ROIC (TTM)

ALEC-24053.0%

PLX31.6%

Cash

ALEC$60M

PLX$27M

Debt

ALEC$10M

PLX$0

Net Cash/Debt

ALEC$50M

PLX$27M

Current Ratio (TTM)

ALEC5.26x

PLX2.94x

Quick Ratio (TTM)

ALEC5.05x

PLX1.91x

Debt/Equity (TTM)

ALEC0.94x

PLX0.00x

Debt/Assets (TTM)

ALEC0.0%

PLX0.0%

Interest Coverage (TTM)

ALECN/A

PLXN/A

Net Debt/EBITDA (TTM)

ALEC0.00x

PLX0.00x

Beta

ALEC0.65

PLX-0.05

52W Performance

ALEC-32.5%

PLX8.2%

YTD Performance

ALEC35.9%

PLX59.8%

% from 52W High

ALEC-38.8%

PLX-12.9%

% from 52W Low

ALEC90.8%

PLX73.7%

Asset Turnover (TTM)

ALEC0.05x

PLX0.85x

FCF Yield (TTM)

ALEC-68.6%

PLX3.4%

Earnings Yield (TTM)

ALEC-51.0%

PLX8.5%

Dividend Yield (TTM)

ALECN/A

PLXN/A

Rule of 40

ALEC-1,225.5

PLX39.7

EV/GP/RG

ALECN/A

PLXN/A

Ticker research

View ALEC research View PLX research

Metric	ALEC Alector Inc	PLX Protalix Biotherapeutics Inc
Market & Valuation
Market Cap	$231M	$224M
Enterprise Value	$181M	$197M
Price	$2.08	$2.78
P/E Ratio	N/A	12.11x
P/S Ratio	16.66x	2.78x
EV/Sales	13.05x	2.44x
EV/EBITDA	3.60x	7.37x
P/B Ratio	19.47x	3.06x
P/FCF Ratio	N/A	29.21x
EV/FCF	-1.14x	25.63x
PEG Ratio	N/A	0.06x
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	3.56x
Revenue & Growth
Revenue (TTM)	$14M	$81M
Revenue Growth (YoY)	-82.9%	30.1%
Forward Rev Growth	281.0%	-19.1%
Profitability
Gross Margin (TTM)	0.0%	69.2%
Operating Margin (TTM)	0.0%	28.9%
EBITDA Margin (TTM)	-879.7%	30.8%
Net Margin (TTM)	-850.1%	23.5%
FCF Margin (TTM)	-1142.6%	9.5%
Net Income (TTM)	$-118M	$19M
FCF (TTM)	$-158M	$8M
EPS (TTM)	-$1.06	$0.23
ROE (TTM)	-29517.0%	31.6%
ROA (TTM)	-4400.0%	20.1%
ROIC (TTM)	-24053.0%	31.6%
Financial Health
Cash	$60M	$27M
Debt	$10M	$0
Net Cash/Debt	$50M	$27M
Current Ratio (TTM)	5.26x	2.94x
Quick Ratio (TTM)	5.05x	1.91x
Debt/Equity (TTM)	0.94x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	-0.05
52W Performance	-32.5%	8.2%
YTD Performance	35.9%	59.8%
% from 52W High	-38.8%	-12.9%
% from 52W Low	90.8%	73.7%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.85x
FCF Yield (TTM)	-68.6%	3.4%
Earnings Yield (TTM)	-51.0%	8.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	39.7
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View PLX research